About Us

For over 60 years delivering quality

Centroflora Group has spared no efforts in valuing Brazilian biodiversity as a source of Innovation for the Phytomedicines market.

With 64 years of history, Centroflora maintains its tradition as a manufacturer of botanical extracts, essential oils and isolated ingredients for the pharmaceutical industry. In recent years, it has also been consolidating itself as a national manufacturer of Active Pharmaceutical Ingredients (APIs), through new partnerships and investments to adapt its production and commercial structure.

Centroflora has technologies and processes that allow the isolation, extraction, concentration and drying of differentiated natural assets, with assured quality and traceability. As a result, it offers the market a wide variety of extracts from different regions of the planet, with special attention to those derived from Brazilian biodiversity, with total sustainability and respect for the environment; in other words, Centroflora has always acted in line with the principles that today are known as ESG.

Centroflora Group includes: (i) Anidro do Brasil; (ii) Phytobios, a company dedicated to radical and disruptive research and development, and (iii) Floravida Institute, a non-profit socio-environmental organization (NGO). In 2018, a joint venture called Brazbio has been created.

Mission

Deliver traced products that provide health and well-being with quality and sustainability.

Vision

To be recognized globally in the manufacture of traceable natural ingredients of high added value with socio-environmental responsibility.

Values

We are driven by passion and pride to be part of Centroflore Group; We are ethical, transparent and committed to results; We develop partnerships with customers, suppliers, employees, government agencies and technology centers for a better world; We cultivate boldness and innovation; People are the essence of our business; Commitment to sociobiodiversity is our hallmark; Global action is what sustains us.

1957

Foundation of Centroflora Group.

1957

1991

Opening of the Drying Plant, in Botucatu-SP. 

1991

2001

Opening of the Botanic Extract Plant-SP.

2001

2002

Creation of Floravida Institute, a non-profit organization managed by the Group.

2002

2003

Acquisition of the Pharmochemical Plant in Paranaíba-PI and creation of the Partnerships for a Better World Program.

2003

2005

Acquisition of the agricultural area in Paranaíba-PI

2005

2008

Creation of the Jaborandi Valorization Program.

2008

2011

Opening of the Oil Extraction Plant in Parnaíba-PI.

2011

2012

Incorporation of 100% of the shares of Phytobios, until then a partner of Centroflora Group.

2012

2014

Creation of Centroflora CMS, a Joint Venture between Centroflora and CMS.

2014

2016

Incorporation of ASM Research Chemicals and L4P Foundation, specializing in pharmaceutical logistics.

2016

2017

Sale of the nutraceutical sector to Givaudan. 

2017

2018

Completion of the CMS Joint Venture and creation of a distribution agreement between Centroflora and CMS (currently C²Pharma)

2018

2018

Creation of Brazbio, a Joint Venture between Givaudan and Centroflora, with shared management and focused on the development of sociobiodiversity production chains, continuing the work developed within the “Partnerships for a Better World Program”.

2018-2

2018

Centroflora IFA: delivery of a synthesis plant in Paranaíba-PI, with an investment of 18 million and a transfer project for the production of new APIs and prospecting for Cannabidiol production. 

2018 – 3

2019

Opening of Centroflora Inova in Campinas (SP)

2019

2020

Opening of the Pilot Plant, of the new plant extract factory in Paranaíba (PI) and the beginning of the works of the new plant in Botucatu (SP).

2020

2021

Start of activities at the new plant in Botucatu (Spray Dryer)

2021

2021

Centroflora Agro

2021